Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

CTIT: Cancer Therapy Induced Thrombocytopenia 1

Interventions

Specimen Handling 483 pembrolizumab 456 Magnetic Resonance Spectroscopy 420 Carboplatin 327 Cyclophosphamide 315 Biopsy 274 Cisplatin 270 Radiotherapy 244 Paclitaxel 229 Gemcitabine 225 Bevacizumab 214 Nivolumab 189 fludarabine 184 venetoclax 174 Drug Therapy 171 Dexamethasone 158 Blood Specimen Collection 158 Oxaliplatin 154 Injections 152 Capecitabine 152 Fluorouracil 145 Docetaxel 144 Radiosurgery 137 Standard of Care 136 Rituximab 125 Pemetrexed 117 durvalumab 114 atezolizumab 110 Leucovorin 110 Radiation 106

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × oprelvekin × 1 year × Clear all

NCT06759636 2026-04-14

FRIENDS-01

The First Affiliated Hospital with Nanjing Medical University

Phase 3 Recruiting

Classical hematology

CTIT: Cancer Therapy Induced Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡